Acquisition: advantages and strategies available

Michael West, Chief Executive Officer, BioTime joined us at the 9th Annual World Stem Cells & Regenerative Medicine Congress to present on ‘Acquisition Strategies.’ Download this presentation now to find out: Pluripotent Stem Cells Two Defining Characteristics of hESCs OPC1–Oligodendrocyte Progenitor Cells Telomerase Cancer Vaccine HyStem Hydrogels –Competitive Advantages Background on BioTime Acquisition Deal Points ..and much more! Get your copy …